Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantihodies in childhood IDDM

Diabetologia

Volumn 39, Issue 9, 1996, Pages 1091-1098

  Falorni, A ^a,d   Ackefors, M ^a   Carlberg, C ^a   Daniels, T ^b   Persson, B ^a   Robertson, J ^c   Lernmark, A ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Synectics Biotechnology   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoantibodies; Autoimmunity; Insulin dependent diabetes mellitus; Radioimmunoassay; Recombinant protein

Indexed keywords

AUTOANTIBODY; EPITOPE; GLUTAMATE DECARBOXYLASE;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0029793724     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00400659     Document Type: Article

References (33)

1. Karlsen AE, Hagopian WA, Grubin CE et al. (1991) Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA 89: 2115-2119
2. Falorni A, Kockum I, Sanjeevi CB. Lernmark A (1995) Pathogenesis of insulin-dependent diabetes mellitus. In: Kendall-Taylor P (ed) Autoimmune Endocrine Disease. Bailliere's Clin Endocrinol Metab 9: 25-46
3. Baekkeskov S, Aanstoot H-J, Christgau S et al. (1990) Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (London) 347: 151-156
4. r. autoantibodies. Diabetes 41: 1355-1359
5. Velloso LA, Kämpe O, Hallberg A, Christmanson L, Betsholtz C, Karlsson FA (1993) Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type I diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J Clin Invest 91: 2084-2090
6. Seissler J, Amann J, Mauch L et al. (1993) Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 92: 1394-1399
7. Petersen JS, Hejnaes KR, Moody A et al. (1994) Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43: 459-467
8. Grubin CE, Daniels T, Toivola B et al. (1994) A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37: 344-350
9. Vandewalle CL, Falorni A, Svanholm S et al. (1995) High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab 80: 846-851
10. Kawasaki E, Takino H, Mayumi Y et al. (1994) Autoantibodies to glutamic acid decarhoxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43: 80-86
11. Falorni A, Grubin CE, Takei I et al. (1994) Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65, 000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 19: 113-125
12. Baekkeskov S, Landin-Olsson M, Kristensen JK et al. (1987) Antibodies to a Mr 64, 000 human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 79: 926-934
13. Bingley PJ, Christie MR, Bonifacio E et al. (1994) Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43: 1304-1310
14. Bingley PJ, Bonifacio E, Gale EAM (1993) Can we really predict IDDM? Diabetes 42: 213-220
15. Hagopian WA, Sanjeevi CB, Kockum I et al. (1995) Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 95: 1505-1511
16. Richter W, Shi Y, Baekkeskov S (1993) Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sc. USA 90: 2832-2836
17. Daw K, Powers A (1995) Two distinct glutamic acid decarboxylase autoantibody specificities in IDDM target different epitopes. Diabetes 44: 216-220
18. Björk E, Velloso LA, Kämpe O, Karlsson FA (1994) GAD-autoantibodies in insulin-dependent diabetes mellitus, stiffman syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 43: 161-165
19. Butler MH, Solimena M, Dirkx R, Hayday A, De Camilli P (1993) Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J Exp Med 178: 2097-2106
20. Li L, Hagopian WA, Brashear R, Daniels T, Lernmark Å (1994) Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients. J Immunology 152: 930-934
21. 3H recombinant human ligands. J Immunol Methods 186: 89-99
22. Landin-Olsson M, Palmer JP, Lernmark Å et al. (1992) Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Diabetologia 35: 1068-1073
23. Li L, Jiang J, Hagopian WA et al. (1995) Differential detection of rat islet and brain glutamic acid decarboxylase (GAD) isoforms with sequence-specific peptide antibodies. J Histochem Cytochem 43: 53-59
24. Michelsen B, Petersen JS, Boel E, Møldrup A, Dyrberg T, Madsen OD (1991) Cloning, characterization and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus (IDDM). Proc Natl Acad Sci USA 88: 8754-8758
25. Bu D-F, Erlander MG, Hitz BC et al. (1992) Two human glutamate decarboxylase, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 89: 2115-2119
26. Solimena M, Aggujaro D, Muntzel C et al. (1993) Association of GAD-65, but not of GAD-67, with the Golgi complex of transfected Chinese hamster ovary cells mediated by the N-terminal region. Proc Natl Acad Sci USA 90: 3073-3077
27. Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF, Harrison LC, participating laboratories (1994) High levels of concordance between assays for glutamate decarboxylase autoantibodies: the first international glutamic acid decarboxylase antibody workshop. Diabetes 43: 1005-1009
28. Schmidli RS, Colman PG, Bonifacio E, participating laboratories (1995) Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second international GADAb workshop. Diabetes 44: 636-640
29. Richter W, Eierman TH, Endl Jet al. (1993) Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies. Diabetologia 36: 785-790
30. Kim J, Namchuck M, Bugawan T et al. (1994) Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65 distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J Exp Med 180: 595-606
31. Ujihara N, Daw K, Gianani R, Boel E, Yu L, Powers AC (1994) Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes. Diabetes 43: 968-975
32. Tuomi T, Rowley MJ, Knowles W et al. (1994) Autoantigenic properties of native and denatured glutamic acid decarboxylase: evidence for a conformational epitope. Clin Immunol Immunopathol 71: 53-59
33. Hallengren B, Falorni A, Landin-Olsson M, Lernmark Å, Papadopoulos KI, Sundkvist G (1996) Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: at diagnosis and following treatment. J Intern Med 239: 63-68